Hyperion Therapeutics
About:
Hyperion Therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases.
Website: http://www.hyperiontx.com
Top Investors: New Enterprise Associates, Sofinnova Investments, EQT Life Sciences, Highland Capital Partners, Bay City Capital
Description:
Hyperion is a biotech company developing therapies to address "orphan or underserved patient populations." They are located in South San Francisco, CA.
Total Funding Amount:
$222M
Estimated Revenue Range:
$100M to $500M
Headquarters Location:
South San Francisco, California, United States
Founded Date:
2006-01-01
Contact Email:
kim.gray(AT)hyperiontx.com
Founders:
Mark Blumling
Number of Employees:
501-1000
Last Funding Date:
2013-03-08
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai